Please assess the completion status of the following clinical trial:

Trial Title: Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com~Inclusion Criteria:~* Symptoms of RA for no more than 12 months prior to enrollment~* Meet American College of Rheumatology/European League against Rheumatism (ACR/EULAR) 2010 criteria for classification of RA~* Treated with Methotrexate (MTX) for at least 12 weeks prior to randomization with a stable oral dose for at least 4 weeks, Subjects must randomize on the maximum tolerated dose of oral methotrexate (minimum of 15 mg and maximum of 25 mg per week), dose of MTX \< 15 mg/week but ≥ 7.5 mg/week is permitted if subjects are intolerant to higher doses~* At least 3 tender \& 3 swollen joints~* Anti-cyclic citrullinated peptide (CCP) \> 3X the upper limit of normal and positive rheumatoid factor~Exclusion Criteria:~* History of other autoimmune diseases (eg, psoriasis, systemic lupus, erythematosus, etc)~* Prior use of non-biologic therapy other than methotrexate~* Prior use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARD) therapy~* Subjects with chronic or recent acute serious infection~Other protocol defined inclusion/exclusion criteria could apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment A (Type: EXPERIMENTAL): Abatacept Single Blind Treatment Period
- Treatment B (Type: ACTIVE_COMPARATOR): Adalimumab Single Blind Treatment Period
- Treatment C (Type: ACTIVE_COMPARATOR): Abatacept Cumulative Treatment Period

Based on this trial design, predict the completion outcome and termination type (if applicable).